From 2015 to 2017, IFN-gamma, recruitment, lipopolysaccharide, tumor necrosis factor-alpha, fatty acid oxidation, rheumatoid arthritis, hypercholesterolemia, in vivo, and tumor-associated macrophage were critical research directions. The gene discussed is IFNG; the disease is familial hypercholesterolemia.